
QT Imaging
A scanning center that provides breast imaging by tomographic transmission ultrasound for patients.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $5.0m | Post IPO Debt | |
Total Funding | 000k |






USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 94 % | - |
EBITDA | 0000 | 0000 | 0000 |
% EBITDA margin | (1669 %) | (725 %) | - |
Profit | 0000 | 0000 | 0000 |
% profit margin | (1483 %) | (883 %) | - |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
R&D % of revenue | 592 % | 337 % | - |
Source: Company filings or news article
Related Content
QT Imaging specializes in advanced medical imaging technology, focusing on the early detection of breast cancer through its proprietary 3D transmission ultrasound technology. This innovative approach allows for the characterization and isolation of tissue types based on the speed of sound, providing true volumetric images and unimpeded visibility of dense breast tissue. The company's primary clients include healthcare providers, diagnostic centers, and research institutions. Operating in the medical imaging market, QT Imaging leverages its FDA-cleared technology to offer a non-invasive, highly accurate alternative to traditional imaging methods. The business model revolves around the sale and leasing of its imaging systems, as well as providing ongoing maintenance and support services. Revenue is generated through direct sales, service contracts, and potential future licensing agreements.
Keywords: 3D ultrasound, breast cancer detection, medical imaging, FDA clearance, tissue characterization, volumetric imaging, dense breast tissue, healthcare providers, diagnostic centers, non-invasive technology.